Cyclopharm (ASX:CYC) Net Interest Margin (Bank Only) %


ASX:CYC Cyclopharm Ltd ASX:CYC
46 GF Score
Price A$0.50
GF Value A$0.84
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Cyclopharm Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

ASX:CYC
46GF Score
Cyclopharm Ltd ASX:CYC
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cyclopharm (ASX:CYC) Overvalued in 2026?

Based on GuruFocus' analysis, Cyclopharm stock appears to be undervalued. The current stock price of A$0.50 is trading 40.5% below its estimated GF Value™ of A$0.84. GuruFocus considers Cyclopharm to be Possible Value Trap.

Key valuation signals for ASX:CYC:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: A$0.84 vs. price of A$0.50 (40.5% below fair value)
  • GF Score™: 46/100 with 7 warning signs

No single metric tells the full story. See the ASX:CYC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cyclopharm Business Description

Address 1 The Crescent, Unit 4, Kingsgrove, Sydney, NSW, AUS, 2208
Cyclopharm Ltd is a health technology company offering solutions related to functional lung ventilation imaging. Its proprietary product Technegas is a broad-spectrum diagnostic lung imaging technology product for the visualisation of pulmonary ventilation and lung function. The company sells its products to healthcare institutions and medical professionals. Maximum revenue is generated from its Technegas products and services, which include the sale of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. Geographically, the company generates maximum revenue from its business in Europe, and the rest from Asia Pacific, Canada, the USA, and other regions.
46GF Score

Get the complete analysis for ASX:CYC

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.50
Price
A$0.84
GF Value